Apr, 2021

Abbas Lugemwa speaks on ‘PentaTr@ining Uganda 2021’


It was a lifetime privilege and honour to host the ‘PentaTr@ining Uganda 2021′ course. This training had originally been planned for 2020, but that schedule got disrupted due to the COVID-19 pandemic. Nevertheless, we still received all the maximum support to make the course happen this year. This was a declaration of trust by Penta Foundation in the work we do as Joint Clinical Research Centre – Mbarara, and a demonstration of commitment by Penta to build capacity for excellence in research and paediatric care.



Apr, 2021

Call for comments on the WHO Zika virus Research and Development Roadmap

Tags: ,

The WHO is calling on the public to share their comments on the newly drafted Zika virus Research and Development (R&D) Roadmap, a key component of the WHO’s R&D Blueprint which is a global strategy and preparedness plan that allows the activation of R&D activities in advance of and during pandemics. Comments can be submitted by completing this form. The Zika virus R&D roadmap aims to accelerate the development and implementation of effective medical countermeasures for the Zika virus so as to reduce morbidity, mortality and transmission of the virus. Zika is […]



Apr, 2021

Useful resources


WHO Update of recommendations on first- and second-line antiretroviral regimens – 2019 Policy brief Authors: WHO Toolkit for research and development of paediatric antiretroviral drugs and formulations Authors: WHO and Unitaid in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group UNICEF Children, HIV and AIDS Global and regional snapshots November 2019 HIV estimates for children dashboard July 2020 HIV/AIDS data July 2020 Children, HIV and AIDS How will progress be […]


We would like to update you on our recent activities